Cleared Traditional

K830058 - MYOGRAPH 2000

K830058 is an FDA 510(k) clearance for MYOGRAPH 2000, manufactured by Prothia USA, Inc.. The device is a Class 2 Anesthesiology device with product code BXN cleared through the Traditional 510(k) pathway after a 59-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1983
Decision
59d
Days
Class 2
Risk

K830058 is an FDA 510(k) clearance for the MYOGRAPH 2000. Classified as Stimulator, Nerve, Battery-powered (product code BXN), Class II - Special Controls.

Submitted by Prothia USA, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 7, 1983 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.2775 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K830058

510(k) Number K830058 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 07, 1983
Decision Date March 07, 1983
Days to Decision 59 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
81d faster than avg
Panel avg: 140d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BXN Device Classification - Class 2, Special Controls

Product Code BXN Stimulator, Nerve, Battery-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.2775
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BXN Stimulator, Nerve, Battery-powered

All 62
Devices cleared under the same product code (BXN) and FDA review panel - the closest regulatory comparables to K830058.
MEDAR APM FORCE TRANSDUCER
K853849 · Medar Corp., Inc. · Jan 1986
PERIPHERAL NERVE STIMULATOR MODEL A400
K852962 · Fisher & Paykel Allied Products , Ltd. · Dec 1985
NERVE STIMULATOR Q10
K843175 · Acm Systems · Aug 1984
MYOTEST NERVE STIMULATOR
K823583 · Prothia USA, Inc. · Dec 1982
STIMPEN
K822139 · Neuro Technology · Sep 1982
DIGISTIM II
K822137 · Beuro Technology · Jul 1982